NeuroOne Medical Technologies Corporation (NMTC)

Market Cap	22.46M
Revenue (ttm)	3.92M
Net Income (ttm)	-12.10M
Shares Out	30.81M
EPS (ttm)	-0.49
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	264,855
Open	0.659
Previous Close	0.661
Day's Range	0.659 - 0.729
52-Week Range	0.602 - 2.000
Beta	0.91
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 12, 2024

About NMTC

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to dev...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 16
• Stock Exchange: NASDAQ
• Ticker Symbol: NMTC
• Website: https://www.n1mtc.com

Financial Performance

In 2023, NMTC's revenue was $3.41 million, an increase of 60.73% compared to the previous year's $2.12 million. Losses were -$11.86 million, 18.6% more than in 2022.